VALEANT PHARMACEUTICALS INTL's ticker is VRX and the CUSIP is 91911K102. A total of 468 filers reported holding VALEANT PHARMACEUTICALS INTL in Q4 2015. The put-call ratio across all filers is 0.90 and the average weighting 1.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2015 | $3,182,000 | -28.7% | 17,839 | -11.2% | 0.15% | -21.5% |
| Q2 2015 | $4,461,000 | +177.3% | 20,081 | +147.9% | 0.19% | +204.9% |
| Q1 2015 | $1,609,000 | +523.6% | 8,101 | +350.1% | 0.06% | +408.3% |
| Q4 2014 | $258,000 | -97.9% | 1,800 | -98.1% | 0.01% | -97.7% |
| Q3 2014 | $12,516,000 | -41.2% | 95,400 | -43.5% | 0.53% | -41.6% |
| Q2 2014 | $21,302,000 | +25.5% | 168,900 | +31.1% | 0.90% | +29.4% |
| Q1 2014 | $16,980,000 | – | 128,800 | – | 0.70% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Chou Associates Management | 1,648,992 | $38,323,000 | 14.52% |
| Paulson & Co. | 20,839,035 | $484,299,000 | 9.89% |
| MILLER VALUE PARTNERS, LLC | 4,999,064 | $116,178,000 | 4.34% |
| GoldenTree Asset Management | 1,140,205 | $26,498,000 | 4.21% |
| Pomelo Capital LLC | 1,760,000 | $40,902,000 | 4.00% |
| Bruce & Co., Inc. | 860,000 | $19,986,000 | 3.98% |
| ValueAct Holdings | 18,033,149 | $419,090,000 | 3.79% |
| Stanley Capital Management, LLC | 318,400 | $7,400,000 | 3.25% |
| Kazazian Asset Management, LLC | 134,784 | $3,132,000 | 2.87% |
| Phoenix Investment Adviser LLC | 58,400 | $1,357,000 | 2.48% |